Showing results (11-20 of 19) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 15, 2016
Age and disability drive cognitive impairment in multiple sclerosis across disease subtypesLuis Ruano, Emilio Portaccio, Benedetta Goretti, et al.Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|April 24, 2019
Aging with multiple sclerosis: prevalence and profile of cognitive impairmentMariana Branco, Luis Ruano, Emilio Portaccio, et al.Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|November 13, 2019
Correction to: Aging with multiple sclerosis: prevalence and profile of cognitive impairmentMariana Branco, Luis Ruano, Emilio Portaccio, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|June 28, 2017
Patients with paediatric-onset multiple sclerosis are at higher risk of cognitive impairment in adulthood: An Italian collaborative studyLuis Ruano, Mariana Branco, Emilio Portaccio, et al.Journal of Neurology, Neurosurgery, and Psychiatry|October 15, 2020
Clinical effectiveness of different natalizumab interval dosing schedules in a large Italian population of patients with multiple sclerosisClara Grazia Chisari, Luigi Maria Grimaldi, Giuseppe Salemi, et al.Lung Cancer (Amsterdam, Netherlands)|October 4, 2015
Combined circulating epigenetic markers to improve mesothelin performance in the diagnosis of malignant mesotheliomaLory Santarelli, Sara Staffolani, Elisabetta Strafella, et al.JAMA Neurology|January 4, 2021
Identifying the Distinct Cognitive Phenotypes in Multiple SclerosisErmelinda De Meo, Emilio Portaccio, Antonio Giorgio, et al.Annals of Clinical and Translational Neurology|January 25, 2025
Pediatric, adult, and late onset multiple sclerosis: Cognitive phenotypes and gray matter atrophyErmelinda De Meo, Emilio Portaccio, Rosa Cortese, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|August 15, 2024
Ocrelizumab in MS patients with persistence of disease activity after alemtuzumab: A multi-center Italian studyCaterina Lapucci, Jessica Frau, Eleonora Cocco, et al.Pageof 2